$613Million | No. of Holdings #24
Sands Capital Ventures, LLC Performance
| Ticker | $ Bought |
|---|---|
| alamar biosciences inc | 114,616,000 |
| odyssey therapeutics inc | 16,371,200 |
| cerebras systems inc | 7,254,320 |
| Ticker | % Inc. |
|---|---|
| coupang inc | 31.34 |
| figma inc | 21.21 |
| snowflake inc | 20.96 |
| toast inc | 20.96 |
| monday com ltd | 20.8 |
| servicetitan inc | 20.8 |
| doordash inc | 14.68 |
| nu hldgs ltd | 8.52 |
| Ticker | % Reduced |
|---|---|
| samsara inc | -7.97 |
| datadog inc | -5.76 |
Sands Capital Alternatives, LLC has about 72.3% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 72.3 |
| Healthcare | 11.3 |
| Technology | 8.8 |
| Consumer Cyclical | 3.8 |
| Communication Services | 3.8 |
Sands Capital Alternatives, LLC has about 16.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 72.3 |
| LARGE-CAP | 16.4 |
| MICRO-CAP | 5.9 |
| MID-CAP | 3.9 |
| SMALL-CAP | 1.5 |
About 0% of the stocks held by Sands Capital Alternatives, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 99.1 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Sands Capital Alternatives, LLC has 24 stocks in it's portfolio. About 80.8% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Sands Capital Alternatives, LLC last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Acumen Pharmaceuticals Inc Sands Capital Ventures, LLC's holding in Acumen Pharmaceuticals Inc over time | 1.62% | 3,720,100 | $9.93M 1.62% | 0%unchanged 0 percentunchanged | |
Candel Therapeutics Inc Sands Capital Ventures, LLC's holding in Candel Therapeutics Inc over time | 0.68% | 405,837 | $4.18M 0.68% | 0%unchanged 0 percentunchanged | |
Coupang Inc Coupang IncCPNG Sands Capital Ventures, LLC's holding in Coupang Inc over time | 3.76% | 1,329,310 | $23.09M 3.76% | 31.34%increased 31.34 percentadded | |
Doordash Inc Doordash IncDASH Sands Capital Ventures, LLC's holding in Doordash Inc over time | 3.84% | 127,562 | $23.54M 3.84% | 14.68%increased 14.68 percentadded | |
Datadog Inc Datadog IncDDOG Sands Capital Ventures, LLC's holding in Datadog Inc over time | 3.43% | 80,851 | $21.05M 3.43% | 5.76%decreased 5.76 percentreduced | |
Inhibikase Therapeutics Inc Sands Capital Ventures, LLC's holding in Inhibikase Therapeutics Inc over time | 4.31% | 13,019,000 | $26.43M 4.31% | 0%unchanged 0 percentunchanged | |
Samsara Inc Samsara IncIOT Sands Capital Ventures, LLC's holding in Samsara Inc over time | 2.73% | 515,658 | $16.72M 2.73% | 7.97%decreased 7.97 percentreduced | |
MNDY Monday Com LtdMonday Com LtdMNDY | 0.97% | 81,982 | $5.93M 0.97% | 20.8%increased 20.8 percentadded | |
NU Nu Hldgs LtdNu Hldgs LtdNU | 15.45% | 7,094,950 | $94.79M 15.45% | 8.52%increased 8.52 percentadded | |
Snowflake Inc Snowflake IncSNOW Sands Capital Ventures, LLC's holding in Snowflake Inc over time | 1.02% | 24,498 | $6.23M 1.02% | 20.96%increased 20.96 percentadded | |
Tarsus Pharmaceuticals Inc Sands Capital Ventures, LLC's holding in Tarsus Pharmaceuticals Inc over time | 0.87% | 85,000 | $5.35M 0.87% | 0%unchanged 0 percentunchanged | |
| 1.65% | 364,879 | $10.15M 1.65% | 20.96%increased 20.96 percentadded | ||
Taysha Gene Therapies Inc Sands Capital Ventures, LLC's holding in Taysha Gene Therapies Inc over time | 0.8% | 724,873 | $4.94M 0.8% | 0%unchanged 0 percentunchanged | |
10x Genomics Inc Sands Capital Ventures, LLC's holding in 10x Genomics Inc over time | 3.01% | 481,770 | $18.47M 3.01% | 0%unchanged 0 percentunchanged | |
Common Stock Alamar Biosciences IncAlamar Biosciences Inc | 18.68% | 4,230,930 | $114.62M 18.68% | Newnew position | |
Com Ser A Klaviyo IncKlaviyo Inc | 9.67% | 3,928,150 | $59.31M 9.67% | 7.63%increased 7.63 percentadded | |
Com Beta Bionics IncBeta Bionics Inc | 9.47% | 3,708,040 | $58.10M 9.47% | 0%unchanged 0 percentunchanged | |
Com Shs Spyglass Pharma IncSpyglass Pharma Inc | 9.07% | 2,500,010 | $55.65M 9.07% | 0%unchanged 0 percentunchanged | |
Com Bioage Labs IncBioage Labs Inc | 3.14% | 786,353 | $19.27M 3.14% | 0%unchanged 0 percentunchanged | |
Common Stock Odyssey Therapeutics IncOdyssey Therapeutics Inc | 2.67% | 875,000 | $16.37M 2.67% | Newnew position | |